Study of the Collaborative Life Skills Program
This study is currently recruiting participants.
Verified September 2012 by University of California, San Francisco
Sponsor:
University of California, San Francisco
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01686724
First received: July 16, 2012
Last updated: September 17, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study tests the effectiveness of a newly developed integrated school-home behavioral intervention for behaviors related to Attention Deficit Hyperactivity Disorder (ADHD). The intervention is implemented by school-based mental health professionals within school settings.
| Condition | Intervention |
|---|---|
|
Attention Deficit Hyperactivity Disorder Symptoms |
Behavioral: Collaborative Life Skills Intervention (CLS) Other: Business As Usual |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Efficacy of the Collaborative Life Skills Program |
Resource links provided by NLM:
Further study details as provided by University of California, San Francisco:
Primary Outcome Measures:
- Symptoms of Attention Deficit Hyperactivity Disorder as defined by DSMIV/V. [ Time Frame: change from baseline on ADHD symptoms at 12 weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Homework Problems Checklist (HPC) [ Time Frame: change from baseline in homework problems at 12 weeks ] [ Designated as safety issue: No ]
- Academic Competency Evaluation Scale (ACES) [ Time Frame: change from baseline in ACES at 12 weeks ] [ Designated as safety issue: No ]
- Homework Problems Checklist (HPC) [ Time Frame: change from baseline in homework problems at 7 months ] [ Designated as safety issue: No ]
- Academic Competency Evaluation Scale (ACES) [ Time Frame: change from baseline in ACES at 7 months ] [ Designated as safety issue: No ]
- Children's Organizational Skills Scale (COSS) [ Time Frame: change from baseline in COSS at 12 weeks ] [ Designated as safety issue: No ]
- Children's Organizational Skills Scale (COSS) [ Time Frame: change from baseline in COSS at 7 months ] [ Designated as safety issue: No ]
- Observations of classroom/school behavior [ Time Frame: change from baseline on observed on-task behavior at 12 weeks ] [ Designated as safety issue: No ]
- Observations of classroom/school behavior [ Time Frame: change from baseline in observed on-task behavior at 7 months ] [ Designated as safety issue: No ]
- Academic achievement [ Time Frame: change from baseline in academic achievement at 12 weeks ] [ Designated as safety issue: No ]
- Academic Achievement [ Time Frame: change from baseline in academic achievement at 7 months ] [ Designated as safety issue: No ]
- Social Skills Improvement Scale [ Time Frame: change from baseline in social/behavioral functioning at 12 weeks ] [ Designated as safety issue: No ]
- Social Skills Improvement Scale [ Time Frame: change from baseline in social/behavioral functioning at 7 months ] [ Designated as safety issue: No ]
- Test of Life Skills Knowledge [ Time Frame: change from baseline in life skills knowledge at 12 weeks ] [ Designated as safety issue: No ]
- Test of Life Skills Knowledge [ Time Frame: change from baseline in life skills knowledge at 7 months ] [ Designated as safety issue: No ]
- Alabama Parenting Questionnaire [ Time Frame: change from baseline in parenting practices at 12 weeks ] [ Designated as safety issue: No ]
- Alabama Parenting Questionnaire [ Time Frame: change from baseline in parenting practices at 7 months ] [ Designated as safety issue: No ]
- Parenting Stress Index [ Time Frame: change from baseline in parenting stress at 12 weeks ] [ Designated as safety issue: No ]
- Parenting Stress Index [ Time Frame: change from baseline in parenting stress at 7 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 504 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | June 2016 |
| Estimated Primary Completion Date: | November 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Business as Usual (BAU)
This group receives services as usual in their schools. They will receive the intervention after follow-up measures are gathered.
|
Other: Business As Usual |
|
Experimental: Collaborative Life Skills Intervention (CLS)
CLS is a 12-week program and includes school, parent, and student components which are integrated via joint teacher, parent, and student meetings and use of integrated behavioral programs in the classroom, on the playground, and at home.
|
Behavioral: Collaborative Life Skills Intervention (CLS)
CLS is a 12-week program and includes school, parent, and student components which are integrated via joint teacher, parent, and student meetings and use of integrated behavioral programs in the classroom, on the playground, and at home.
|
Eligibility| Ages Eligible for Study: | 7 Years to 11 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Attending a participating school and in 2-5th grade
- Referral by LSP as a child with apparent ADHD-related problems
- ≥ 6 symptoms (item score ≥ 2) of Inattention or Hyperactivity-Impulsivity on the pooled parent and teacher Child Symptom Inventory
- ≥ 3 on the Impairment Rating Scale by parent and teacher (cross-situational impairment)
- FSIQ or VIQ ≥ 80 (necessary for cognitive demands of the child skills curriculum)
- Caretaker consents to participate in treatment, child assents to participate
Exclusion Criteria:
- Presence of conditions that are incompatible with this study's treatment.
- severe visual or hearing impairment,
- severe language delay,
- psychosis,
- pervasive developmental disorder
- Parent or child does not read or speak English or does not read or speak Spanish for our Spanish language implementation of CLS (inability to complete assessment measures or participate in group treatments).
- Child is in an all-day special education classroom (children in these classrooms are frequently receiving intensive behavior modification programs such that the intervention would be expected to require modification for use in these settings)
- Children taking psychotropic medication for any reason other than to treat ADHD
- Children planning to change (start or stop) psychotropic medication
- Children who have changed a regimen of psychotropic medication (started or stopped) within 30 days prior to screening
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01686724
Contacts
| Contact: Linda Pfiffner, PhD | 415-476-7418 | lindap@lppi.ucsf.edu |
Locations
| United States, California | |
| University of California San Francisco | Recruiting |
| San Francisco, California, United States, 94143 | |
| Principal Investigator: Linda Pfiffner, PhD | |
Sponsors and Collaborators
University of California, San Francisco
Investigators
| Principal Investigator: | Linda Pfiffner, PhD | University of California, San Francisco |
More Information
No publications provided
| Responsible Party: | University of California, San Francisco |
| ClinicalTrials.gov Identifier: | NCT01686724 History of Changes |
| Other Study ID Numbers: | R324A120358 |
| Study First Received: | July 16, 2012 |
| Last Updated: | September 17, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, San Francisco:
|
Attention Deficit Hyperactivity Disorder Psychosocial Intervention Behavioral Intervention School-home collaborative intervention |
Additional relevant MeSH terms:
|
Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Mental Disorders Diagnosed in Childhood Mental Disorders |
Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on June 17, 2013